Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

Cancer Institute Spins-Off Company, Gains Licensing Deal

Red blood cells held together with platelets, in blue, and fibrin, in yellow (NIH.gov)

14 October 2015. Ontario Institute for Cancer Research is spinning off a new enterprise to discover therapies for blood-related cancers, and will partner with Janssen Biotech Inc. to take those therapies to market. The licensing deal between Novera Therapeutics . . . → Read More: Cancer Institute Spins-Off Company, Gains Licensing Deal

Universal Wireless Charging Device Designed

(sethink, Pixabay)

14 October 2015. Engineering researchers designed a prototype device that can simultaneously charge mobile phones compatible with leading wireless charging specifications. Dukju Ahn and Patrick Mercier at University of California in San Diego describe their device in a recent issue of the journal IEEE Transactions on Power Electronics (paid subscription required).

. . . → Read More: Universal Wireless Charging Device Designed

Institute, GlaxoSmithKline ID Tuberculosis Candidates

Tuberculosis bacteria (DoE.gov)

13 October 2015. A biomedical research institute partnered with a lab backed by pharmaceutical company GlaxoSmithKline to identify candidates for drugs that act on bacteria causing tuberculosis. The team from Center for Infectious Disease Research in Seattle and Tres Cantos Open Lab Foundation, a lab in Spain sponsored by GlaxoSmithKline, . . . → Read More: Institute, GlaxoSmithKline ID Tuberculosis Candidates

Spin-Off to Provide Lower-Cost Molecular Imaging Technology

Exchange-Paint image showing microtubules in green, mitochondria in purple, Golgi apparatus in red, and peroxisomes in yellow, from a single human cell. (Maier Avendano, Wyss Institute, Harvard University)

13 October 2015. A new enterprise based on research at Harvard University is offering a technology that allows ordinary microscopes to display high resolution images . . . → Read More: Spin-Off to Provide Lower-Cost Molecular Imaging Technology

Study Shows Blood Test Finds Early Pancreatic Cancer

Pancreatic cancer cells in culture (Anne Weston, London Research Institute, via National Institute of General Medical Sciences)

12 October 2015. An evaluation of a blood test to find early stages of pancreatic cancer showed the test successfully identified early-stage cancer in the vast majority of study participants with the disease. The findings published . . . → Read More: Study Shows Blood Test Finds Early Pancreatic Cancer

Patent Awarded for Slower Digested Wheat

Shree Krishna Dhital (Wikimedia Commons)

12 October 2015. A type of wheat digested more slowly than regular wheat, and thus releases glucose more slowly into the blood stream, received a patent from the U.S. Patent and Trademark Office. Patent number 9,150,839, titled “Wheat with increased resistant starch levels ,” was awarded on 2 . . . → Read More: Patent Awarded for Slower Digested Wheat

Chip Device in Development to Simulate Human Gut

Schematic illustration of colon tissue with pits inhabited by stem cells at the bottom, and precursor and differentiated cells rising to the top. (Scott Magness, University of North Carolina, Chapel Hill)

9 October 2015. A team of medical researchers and engineers in North Carolina is developing a miniaturized device derived from human stem . . . → Read More: Chip Device in Development to Simulate Human Gut

Harvard Spin-Off Commercializing Sepsis Treatment

Sepsis blood-filtering device (Wyss Institute, Harvard University)

9 October 2015. A new enterprise spun-off from Harvard University is developing a device for treating sepsis, a life-threatening infection often contracted in hospitals. The company, Opsonix Inc. in Boston, also raised $8 million in its first round of venture funding.

Opsonix is licensing a technology . . . → Read More: Harvard Spin-Off Commercializing Sepsis Treatment

Eli Lilly Expanding NYC Labs for Cancer Therapies

Molecular biology lab at Eli Lilly and Co. in New York (A. Kotok)

9 October 2015. The pharmaceutical company Eli Lilly and Company is expanding its research labs in New York City to boost discoveries of cancer therapies that harness the immune system. Lilly expects to hire 50 more research and support staff . . . → Read More: Eli Lilly Expanding NYC Labs for Cancer Therapies

On Assignment

(A. Kotok)

8 October 2015. We’re covering a story in New York today, so we will not be posting any items. We’ll resume our regular posting tomorrow.

* * *